Evaluation of the effectiveness of ferrous sulfate in preventing recurrence of febrile convulsion

Comparison of the effectiveness of two different doses of ferrous sulfate on recurrence rate, one year after the first febrile convulsion(FC) in children one to five years old without iron deficiency anemia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200728048243N1

Enrollment

100

Registered

2021-05-27

Start date

2021-05-26

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

febrile convulsion. Febrile convulsions

Interventions

Intervention 1: Intervention group 1: receiving ferrous sulfate drops of 1 mg / kg. Intervention 2: Intervention group 2: receiving ferrous sulfate drops of 3 mg / kg.

Eligibility

Sex/Gender

All

Age

12 Months to 60 Months

Inclusion criteria

Inclusion criteria: The Age of the Child should be in the Range of 12 to 60 Months With first febrile convulsion Normal hemoglobin level and mean corpuscular volume(MCV)

Exclusion criteria

Exclusion criteria: The Patient has Mental Retardation or Developmental Delay The Patient has a history of previous afebrile seizure Existence of Serious Systemic Disease in the Patient(Heart,Liver,Renal Dysfunction ,Rheumatology Disease,Peptic Ulcer,IBD) with acute CNS infection : meningitis , encephalitis

Design outcomes

Primary

Measure	Time frame
Repeated febrile seizures. Timepoint: One year. Method of measurement: observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Zakerzadeh

Yazd University of Medical Sciences

s.zakerzadeh@stu.ssu.ac.ir+98 35 3628 4379

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026